首页 >
法规速递
-
Document: Medicine shortage communication (MSC): Victoza 6 mg/mL solution for injection in pre-filled pen (liraglutide)-2025/9/5
2025-09-08查看详情 > -
E20 Adaptive Designs for Clinical Trials-2025/9/30
2025-10-08查看详情 > -
Page: Substance and product data management services-2025/11/14
2025-11-17查看详情 > -
Document: Questions and answers on post approval change management protocols (PACMP) - Revision 1-2025/12/11
2025-12-12查看详情 > -
Page: Environmental risk assessment for immunological veterinary medicinal products - Scientific guideline-2026/1/23
2026-01-26查看详情 > -
Page: One Health approach-2026/3/2
2026-03-03查看详情 > -
国家药监局关于发布仿制药参比制剂目录（第一百零三批）的通告（2026年第8号）-2026/3/30
2026-03-31查看详情 > -
Page: Parallel scientific advice and special development aspects or product types-2026/5/12
2026-05-13查看详情 > -
Assessing User Fees Under the Over-the-Counter Monograph Drug User Fee Program (Draft)-2022/11/1
2022-11-30查看详情 > -
Draft Guidance: Pediatric Drug Development Under the Pediatric Research Equity Act and the Best Pharmaceuticals for Children Act: Scientific Considerations-2023/5/17
2023-05-18查看详情 >
